Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rare severe constrictive pericarditis complication in Erdheim-Chester disease: A case report and literature review.
Miyazaki T, Kamimura D, Wakamatsu M, Konishi M, Matsumura A, Teshigawara H, Teranaka H, Koyama S, Takahashi H, Kunimoto H, Enaka M, Hagihara M, Matsumoto K, Yamazaki E, Nakajima H. Miyazaki T, et al. Among authors: teranaka h. J Clin Exp Hematop. 2024 Jul 31. doi: 10.3960/jslrt.24006. Online ahead of print. J Clin Exp Hematop. 2024. PMID: 39085132 Free article.
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.
Akimoto M, Miyazaki T, Takahashi H, Saigusa Y, Takeda T, Hibino Y, Tokunaga M, Ohashi T, Matsumura A, Teshigawara H, Suzuki T, Teranaka H, Nakajima Y, Matsumoto K, Hashimoto C, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Nakajima H. Akimoto M, et al. Among authors: teranaka h. Int J Hematol. 2024 Feb;119(2):164-172. doi: 10.1007/s12185-023-03700-0. Epub 2024 Jan 17. Int J Hematol. 2024. PMID: 38233702
Prognostic significance of the CFA ratio for newly diagnosed acute myeloid leukemia: A multicenter retrospective study.
Sakuma T, Fujisawa S, Tanaka M, Hagihara M, Fujita H, Fujimaki K, Katsuki K, Akimoto M, Tanaka M, Matsumura A, Teshigawara H, Suzuki T, Teranaka H, Nakajima Y, Miyazaki T, Tachibana T, Matsumoto K, Sakai R, Kanamori H, Nakajima H. Sakuma T, et al. Among authors: teranaka h. Hematol Oncol. 2024 Jan;42(1):e3228. doi: 10.1002/hon.3228. Epub 2023 Sep 20. Hematol Oncol. 2024. PMID: 37731313
Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis.
Ohashi T, Takase-Minegishi K, Maeda A, Hamada N, Yoshimi R, Kirino Y, Teranaka H, Kunimoto H, Hagihara M, Matsumoto K, Namkoong H, Horita N, Nakajima H. Ohashi T, et al. Among authors: teranaka h. J Hematol. 2023 Apr;12(2):66-74. doi: 10.14740/jh1090. Epub 2023 Apr 30. J Hematol. 2023. PMID: 37187501 Free PMC article.
Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7.
Kunimoto H, Fukuchi Y, Murakami K, Ikeda J, Teranaka H, Kato I, Miyazaki T, Enaka M, Mitsuhashi T, Yamazaki E, Kameyama K, Murata M, Okamoto S, Nakajima H. Kunimoto H, et al. Among authors: teranaka h. Hemasphere. 2020 Sep 17;4(5):e469. doi: 10.1097/HS9.0000000000000469. eCollection 2020 Oct. Hemasphere. 2020. PMID: 33163905 Free PMC article.
Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
Ando T, Fujisawa S, Teshigawara H, Matsumura A, Sakuma T, Suzuki T, Teranaka H, Ogusa E, Ishii Y, Miyashita K, Takahashi H, Nakajima Y, Miyazaki T, Hagihara M, Matsumoto K, Yamazaki E, Nakajima H. Ando T, et al. Among authors: teranaka h. Int J Hematol. 2020 Jul;112(1):46-56. doi: 10.1007/s12185-020-02870-5. Epub 2020 May 25. Int J Hematol. 2020. PMID: 32451786